Biomarkers: The Numbers That Actually Predict Your Health

Your last doctor's visit probably ended with "everything looks normal." Maybe you got a copy of your blood work, glanced at it, saw nothing flagged in red, and moved on. That interaction -- the one most people consider a clean bill of health -- is almost comically insufficient.

A standard metabolic panel catches problems that already exist. It's reactive medicine. Biomarker tracking, done properly, flips that model entirely. It catches problems that are developing -- insulin resistance years before diabetes, inflammatory drift years before cardiovascular events, hormonal decline years before you feel it. The difference between "normal range" and "optimal range" is where preventive health actually lives.

What a Biomarker Actually Is

A biomarker is any measurable indicator of a biological state. That's deliberately broad. Your resting heart rate is a biomarker. So is your fasting glucose, your grip strength, your VO2 max, the ratio of your waist circumference to your height, and the concentration of C-reactive protein floating in your blood.

The FDA defines biomarkers as "characteristics that are objectively measured and evaluated as indicators of normal biological processes, pathogenic processes, or pharmacological responses to therapeutic intervention." In practice, what makes a biomarker useful is whether it reliably predicts something you care about -- disease risk, rate of aging, response to an intervention -- before that thing becomes obvious through symptoms alone.

Not all biomarkers require a blood draw. Body composition metrics like body fat percentage, lean mass, and BMI are biomarkers you can track at home. So are sleep metrics from a wearable device. The most powerful picture comes from layering blood-based markers with functional and anthropometric ones.

The Biomarkers Worth Tracking

There are hundreds of measurable biomarkers. Most people don't need hundreds. They need the right 15-20, interpreted in context, tracked over time. Here are the categories that matter most for someone focused on healthspan rather than acute illness.

Metabolic Health

Fasting glucose is the starting point but not the full story. A fasting glucose of 95 mg/dL is "normal" but already trending toward insulin resistance. Fasting insulin is far more sensitive -- it rises years before glucose does. An optimal fasting insulin is under 5-6 uIU/mL, though most labs won't flag anything under 25. HbA1c gives you a 90-day average of blood sugar control and is more stable than a single fasting glucose reading. Together, these three markers tell you whether your metabolic machinery is healthy or quietly deteriorating.

Lipid panels need more nuance than "good cholesterol" and "bad cholesterol." Total LDL matters less than LDL particle count (LDL-P) or apolipoprotein B (ApoB), which more directly reflect atherogenic risk. Triglyceride-to-HDL ratio is an underrated metric -- a ratio above 2.0 suggests insulin resistance even when fasting glucose looks fine.

Inflammation

High-sensitivity CRP (hs-CRP) is the most accessible marker of systemic inflammation. Levels below 1.0 mg/L are ideal; above 3.0 significantly increases cardiovascular risk. Single readings can spike from infections or acute stress, so trending it over multiple draws is more informative than any single value.

Homocysteine is linked to cardiovascular risk and B-vitamin status. Levels above 10-12 umol/L warrant attention, and it's often correctable through methylfolate, B12, and B6 supplementation.

Hormonal

Testosterone (total and free) in men, estradiol and progesterone in women -- these decline with age, but the rate of decline varies enormously between individuals. Tracking your own trajectory matters more than comparing to population averages. DHEA-S is an adrenal hormone that drops steadily from your mid-twenties and is sometimes used as a marker of biological aging. Thyroid function (TSH, free T3, free T4) governs metabolic rate, energy, and body composition and is frequently sub-optimal in people who feel "fine."

Organ Function and Blood Health

ALT and AST (liver enzymes), creatinine and eGFR (kidney function), and a complete blood count are foundational. These are the basics that most annual panels already include, but they're worth watching longitudinally rather than just checking for red flags at a single time point.

From Numbers to Insight

Raw biomarker values are only useful in context. A single fasting glucose reading tells you very little. A fasting glucose reading alongside fasting insulin, HbA1c, and your body composition trends over 12 months tells you a story.

This is where composite scoring becomes powerful. The phenotypic age model developed by Levine (2018) takes nine routine blood biomarkers -- albumin, creatinine, glucose, CRP, lymphocyte percent, mean cell volume, red cell distribution width, alkaline phosphatase, and white blood cell count -- and calculates a single number representing your biological rate of aging. If your phenotypic age is lower than your chronological age, your body is aging slower than average. If it's higher, something in your lifestyle, environment, or genetics is accelerating the process.

The phenotypic age calculator runs this calculation from a standard blood panel. Paired with an understanding of biological versus chronological age, it transforms routine lab work into an actionable aging metric you can track over time.

Anthropometric biomarkers add another layer. BMI is a blunt instrument -- it can't distinguish muscle from fat -- but combined with body fat percentage and lean body mass, you get a much richer picture of metabolic risk and physical resilience. Two people with identical BMIs can have wildly different health trajectories depending on their body composition.

Building a Tracking Practice

The hardest part isn't getting blood drawn. It's doing it consistently enough to see trends. A single snapshot is nearly useless for preventive purposes. Two data points a year -- minimum -- over several years is where the value compounds.

Get comprehensive panels, not just the basics. Standard annual physiology panels miss fasting insulin, hs-CRP, ApoB, homocysteine, and hormonal markers. Ask for them specifically, or use a direct-to-consumer lab service that includes them.

Track in a centralized place. Scattered PDFs from different labs are almost impossible to trend. Whether it's a spreadsheet, a health app, or Huvolve's dashboard that pulls in data from your wearable devices, the point is longitudinal visibility.

Interpret changes, not just levels. A CRP that moves from 0.5 to 1.8 over two years is telling you something, even though both values are technically "normal." A fasting insulin creeping from 4 to 9 over three years is early metabolic drift. These trends are invisible if you only look at individual results against static reference ranges.

Act on what you find. Biomarker tracking without behavior change is just data collection. If your hs-CRP is elevated, address the likely drivers -- poor sleep, excess body fat, chronic stress, inflammatory diet. If your fasting insulin is rising, adjust your carbohydrate intake and exercise patterns. The data should drive decisions.

Biomarkers are not crystal balls. They don't guarantee outcomes, and they can't capture everything that matters about health. But they're the closest thing available to an early warning system -- one that catches the slow, silent processes behind most chronic disease years before symptoms appear. The people who use them well tend to be the ones who stay ahead of their own biology instead of reacting to it after the fact.

References

1. Strimbu, K., & Tavel, J. A. (2010). "What are biomarkers?" Current Opinion in HIV and AIDS, 5(6), 463-466.
2. FDA-NIH Biomarker Working Group. (2016). "BEST (Biomarkers, EndpointS, and other Tools) Resource." Food and Drug Administration (US).
3. Levine, M. E., et al. (2018). "An epigenetic biomarker of aging for lifespan and healthspan." Aging, 10(4), 573-591.
4. Ridker, P. M. (2003). "C-reactive protein: a simple test to help predict risk of heart attack and stroke." Circulation, 108(12), e81-e85.
5. Sniderman, A. D., et al. (2011). "Apolipoprotein B particles and cardiovascular disease: a narrative review." JAMA Internal Medicine, 172(1), 76-82.
6. Volek, J. S., et al. (2005). "Body composition and hormonal responses to a carbohydrate-restricted diet." Metabolism, 54(7), 864-874.
7. López-Otín, C., et al. (2013). "The hallmarks of aging." Cell, 153(6), 1194-1217.
8. Wang, T. J., et al. (2011). "Metabolite profiles and the risk of developing diabetes." Nature Medicine, 17(4), 448-453.